Company Data

MAIA Biotechnology Inc.

Fundamental Analysis:
โ€Œ
MAIA Biotechnology Inc.
โ€Œ
MAIA Biotechnology Inc.
Fundamental Analysis:
Ticker
MAIA
Current Price
$3.18 0.95%
Market Cap
$69.4M
Price Target
Refer to Report
Volume
145.1K
52wk Range
$0.82 - $5.99
Advanced Market Data

Overview

MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit www.maiabiotech.com.

Inbox Intel from Channelchek.

Informed investors make more money. And itโ€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy